[1]
Hare, J.I.; Lammers, T.; Ashford, M.B.; Puri, S.; Storm, G.; Barry, S.T. Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. Adv. Drug Deliv. Rev., 2017, 108, 25-38.
[2]
Komiyama, M.; Yoshimoto, K.; Sisido, M.; Ariga, K. Chemistry can make strict and fuzzy controls for bio-systems: DNA nanoarchitectonics and cell-macromolecular nanoarchitectonics. Bull. Chem. Soc. Jpn., 2017, 90(9), 967-1004.
[3]
Anselmo, A.C.; Mitragotri, S. Impact of particle elasticity on particle-based drug delivery systems [J]. Adv. Drug Deliv. Rev., 2017, 108, 51-67.
[4]
Kitaoka, C.; Asano, T.; Fujino, T. Direct measurement and quantification of drugs and their metabolites in urine by MALDI-MS using zeolite. Bull. Chem. Soc. Jpn., 2017, 90(2), 154-160.
[5]
Ariga, K.; Minami, K.; Ebara, M. What are the emerging concepts and challenges in NANO[quest] Nanoarchitectonics, hand-operating nanotechnology and mechanobiology. Polym. J., 2016, 48(4), 371-389.
[6]
Chinese Pharmacopoeia Commission. Pharmacopeia of the people’s
Republic of China[S]. Beijing: China Medical Science Press,. 2015; pp.280-281.
[7]
Qian, Y.; Wu, Z.J. Anti-infection and anti-pyretic effect of minor dicoction of Bupleurum: An experimental study. Chin. J. Nosocomiol., 2008, 18(4), 576-578.
[8]
Yang, Z.G.; Chen, A.Q.; Sun, H.X. Research progress on pharmacological action of Radix Bupleuri. China J. Veterin. Med, 2005, 39(5), 27-30.
[9]
Qian, Y.; Wu, Z. Experimental study on the anti-infection and antipyretic effect of Xiao Chaihu Decoction. Chin. J. Nosocom. Infect, 2008, 18(4), 576-578.
[10]
Xue, Y.; Bai, J.Y. Comparative study on Antipyretic constituents of Radix Bupleuri. Pharmacol. Clin. Chin. Mat. Med, 2003, 19(1), 11-12.
[11]
Xie, D.H.; Cai, B.C.; An, Y.Q. Advances in research on chemical constituents and pharmacological effects of Bupleurum saponins. J. Nanjing Univ. Chin. Med., 2007, 23(1), 63-65.
[12]
Zhu, L.X.; Liu, S.Z.; Gu, Z.L. Pharmacological effects of Bupleurum chinense and its application in anti hepatic fibrosis. Chin. Tradit. Herbal Drugs, 2002, 33(10)
[13]
Zu, N.; Li, P. Physiological effects of Bupleurum saponin and its clinical significance. Chin. J. Info. Tradit. Chin. Med, 2005, 12(4), 94-96.
[14]
Li, Y. Experimental study of the effect of Xiao Chaihu Decoction
and its disassembled side on influenza virus in vitro [D]. Hubei
Univ. Chin. Med., 2010.
[15]
Bai, Z.; Wang, Y.; Jia, T. Research Progress on the pharmacological
action of Bupleurum Bupleurum[C]. Member congress of Chinese medicine processing branch of Chinese Medicine Association. 2007.
[16]
Chen, J.; Duan, M. Zhao, Ling, F.; Xiao, K.; Li, Q.; Li, B.; Lu, C.; Qi, W.; Zeng, Z.; Liao, M.; Liu, Y.; Chen, W. Saikosaponin A inhibits influenza A virus replication and lung immunopathology. Oncotarget, 2015, 6(40), 42541-42556.
[17]
Zhang, Y. Clinical observation on treatment of 56 cases of mumps with Bupleurum and Ribavirin injection. Tianjin J. Tradit. Chin. Med., 2000, 17(3), 45-48.
[18]
Liao, J.P.; Chen, Y. To observe the clinical curative effect of ribavirin plus Zijinding on mumps. Jiangxi J. Tradit. Chin. Med., 2002, 33(4), 44-47.
[19]
Huang, W.; Zhao, Y.; Sun, R. Research progress of hepatoprotective effect and hepatotoxicity of Bupleurum chinense. Chin. J. Pharmacovigil., 2011, 8(1), 38-41.
[20]
Zhan, X.J.; Cai, P.; Liu, X.F. Effects of total flavonoids from Bupleurum chinense on ANIT induced intrahepatic cholestasis in rats. Chin. Pharmacol. Bull, 2010, 26(6), 780783.
[21]
Luo, L.; Wu, H.L.; Ji, P. Total flavonoids from the Bupleurum smithii Wolff var. Parvifolium alleviates α-naphthyl isothiocyanate-induced liver injury with acute jaundice in rats. Chin. J. Biochem. Mol. Biol., 2012, 28(10), 946-951.
[22]
Song, X.; Ren, T.; Zhou, Z. Anti-tumor and immunomodulatory activities induced by an alkali-extracted polysaccharide BCAP-1 from Bupleurum chinense via NF-κB signaling pathway. Int. J. Biol. Macromol., 2017, 95, 357-362.
[23]
Hu, S.C.; Lee, I.T.; Yen, M.H. Anti-melanoma activity of Bupleurum chinense, Bupleurum kaoi and nanoparticle formulation of their major bioactive compound saikosaponin-d. J. Ethnopharmacol., 2016, 179, 432-442.
[24]
Xia, W.; Cui, X.Y.; Cui, Q.Y. Inhibitory effect of Saikosaponin d(SSd)on proliferation of K562 cells. J. Beihua Univ. Nat. Sci., 2002, 3(2), 113-115.
[25]
Wang, Y.L.; He, S.X.; Luo, J.Y. Progress in research on antitumor activity of saikosaponin and its mechanism. J. Integr. Med., 2006, 4(1), 98-100.
[26]
Shen, X.; Zhao, Z.Y. Research progress of Bupleurum active constituents and pharmacological effect on liver complaint. World Biotechnol., 2014, 2, 100.
[27]
Huang, W.; Sun, R. Advances in research on saikosaponin chemical constituents and pharmacological and toxicological effects. Pharmacol. Clin. Chin. Mat. Med., 2010, 71-74.
[28]
Wang, Y.X. Y.X.; Liu, Q.Y.; Zhang, M. Polysaccharides from Bupleurum Induce Immune Reversal in Late Sepsis [J]. Shock, 2017.
[29]
Yen, M.H.; Lin, C.C.; Yen, C.M. The immunomodulatory effect of saikosaponin derivatives and the root extract of Bupleurum kaoi in mice [J]. Phytother. Res., 2010, 9(5), 351-358.
[30]
Xu, S.M.; Zheng, K.J.; He, J.Y. Modulation of electrical activity on epilepsy model by Bupleurum chinense. Can. J. Appl. Physiol., 2002, 18(3), 294-296.
[31]
Yang, Z.G.; Chen, A.Q.; Sun, H.X. Research progress on pharmacological action of Radix Bupleuri. China J. Veterin. Med, 2005, 39(5), 27-30.
[32]
Liu, Y.; Liao, W.P.; Gao, M.M. Experimental study on anticonvulsant effect of extracts from Radix Bupleuri. J. New Chin. Med, 2001, 33(9), 76-77.
[33]
An, Y.M.; Jie, C.Y. Research progress of Bupleurum chinense. Ginseng Res, 2001, 13(1), 12-14.
[34]
Tang, W.J.; Lu, X.H.; Zhou, D.X. Study on analgesic effect of
Bupleurum chinense. Hunan J. Tradit. Chin. Med., 2003, 52-53.
[35]
Chen, Y.; Su, S. Research Progress on chemical constituents and pharmacological effects of Bupleurum. Heilongjiang Med. J., 2014, 3, 630-633.
[36]
Huang, W.; Lv, Z.; Sun, R. Research Development on chemincal compositions in bupleurum chinense related with efficacy and toxicity [J]. Chin. J. Pharmacovigil, 2013, 10(09), 545-548.
[37]
Wo, Y.; Yao, L.; Su, S. Progress of Chemical Constituents of Bupleurum Chinese [J]. Heilongjiang Med. J., 2011, 24(2), 215-217.
[38]
Zhou, Y.; Wang, Y.; Ma, Z. Chromatographic fingerprint analysis of Bupleuri Radix by HPLC-ELSD [J]. J. Chin. Pharm. Sci., 2013, 22(1), 40-46.
[39]
Sun, B. Study on the chemical composition and antianaphylaxis of Bupleurum chinensis; Shenyang Pharmaceutical University, 2005. D
[40]
Tang, Z. Study on the chemical composition and quality of Bupleurum
chinensis [D]. Beijing Univ. Chin. Med, 2010.
[41]
Zhu, L.; Liang, Z.T.; Yi, T.; Ma, Y.; Zhao, Z-Z.; Guo, B-L.; Zhang, J-Y. Hu-Biao. Comparison of chemical profiles between the root and aerial parts from three Bupleurum species based on a UHPLC-QTOF-MS metabolomics approach [J]. Bmc Complement. Alternat. Med, 2017, 17(1), 305.
[42]
Xu, N.; Shi, Y.N.; Zhong, X.; Cao, Y.; Wang, L.; Jia, T-Z. A new saikogenin from the roots of Bupleurum bicaule [J]. Chin. J. Nat. Med., 2014, 12(4), 305.
[43]
Sun, Z.; Lv, X.; Xu, G.; Su, R.; Zhao, Z. Chemical constituents of volatile oil from different parts of Bupleurum chinense in gansu by GC-MS [J]. Chin. J. Experiment. Tradit. Med. Formul, 2012, 18(9), 75-78.
[44]
Li, X.Q.; Sun, X.Y.; He, Z.G. Study on extraction method of volatile oil from Bupleurum chinense. Chin. Pharmaceut. J., 2004, 39(2), 103-105.
[45]
Liu, Y.F.; Yan, Y.N.; Liu, Y.H. Supercritical fluid extraction of essential oil from Bupleurum chinense and its chemical composition analysis. Chin. Arch. Tradit. Chin. Med., 2005, 23(4), 663-665.
[46]
Liu, Y.F.; Yan, Y.N.; Liu, Y.H. GC-MS analysis of volatile oil from Bupleurum Fruits. Chin. Tradit. Herbal Drugs, 2005, 36(5), 671-672.
[47]
Shi, Z.; Chen, R.; Chen, Y. Study on the chemical composition of the essential oil extracted from Bupleuri chinese by different methods. [J]. J. Nanjing Univ. Tradit. Chin. Med., 2015, 31(06), 576-578.
[48]
Ge, F.H.; Li, Y.; Xie, J.M. Study on supercritical CO2 extraction of volatile oil and its saponins from Bupleurum chinense. China J. Chin. Mat. Med., 2000, 25(3), 149-153.
97
8
